ABEONA THERAPEUTICS
Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B. Its multi-platform expertise across the manufacture, delivery, development, and discovery of the novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company’s robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery.
ABEONA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Manufacturing Medical Device
Founded:
1989-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.abeonatherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(216)287-5408
Total Funding:
274.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Scott Schorer Director @ Abeona Therapeutics
Director
2014-06-01
Greg Gin Vice President, Investor Relations and Corporate Communications @ Abeona Therapeutics
Vice President, Investor Relations and Corporate Communications
2020-05-01
Edward Carr CFO and Principal Financial Officer @ Abeona Therapeutics
CFO and Principal Financial Officer
2021-08-01
Jon Voss Vice President & Head of Quality @ Abeona Therapeutics
Vice President & Head of Quality
2021-10-01
Victor Paulus SVP,Head of Regulatory affairs @ Abeona Therapeutics
SVP,Head of Regulatory affairs
Douglas McCarty Scientific Founder @ Abeona Therapeutics
Scientific Founder
Jay Bircher CTO @ Abeona Therapeutics
CTO
2020-02-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-12-19 | RF Wireless Solutions | RF Wireless Solutions acquired by Abeona Therapeutics | N/A |
Investors List
Jefferies
Jefferies investment in Post-IPO Equity - Abeona Therapeutics
H. C. Wainwright & Co.
H. C. Wainwright & Co. investment in Post-IPO Equity - Abeona Therapeutics
Maxim Group
Maxim Group investment in Post-IPO Equity - Abeona Therapeutics
FBR & Co
FBR & Co investment in Post-IPO Equity - Abeona Therapeutics
RBC Capital Markets
RBC Capital Markets investment in Post-IPO Equity - Abeona Therapeutics
Cantor Fitzgerald
Cantor Fitzgerald investment in Post-IPO Equity - Abeona Therapeutics
Stop Sanfilippo
Stop Sanfilippo investment in Grant - Abeona Therapeutics
George Soros
George Soros investment in Post-IPO Equity - Abeona Therapeutics
Key Employee Changes
Official Site Inspections
http://www.abeonatherapeutics.com Semrush global rank: 4.71 M Semrush visits lastest month: 2.02 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Abeona Therapeutics"
Investor Relations :: Abeona Therapeutics Inc. (ABEO)
Previously, Mr. Amoroso worked at Celgene for six years in several commercial roles before serving as the organization’s Commercial Lead for CAR T-cell therapy programs. In this capacity, he helped Celgene develop an …See details»
Abeona Therapeutics - Crunchbase Company Profile
Organization. Abeona Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Abeona Therapeutics: Revenue, Worth, Valuation & Competitors …
Organization Abeona Therapeutics abeonatherapeutics.com . Location. New York City, New York, United States. Industry ... For more information, visit www.abeonatherapeutics.com. Abeona …See details»
Abeona Therapeutics (ABEO) Company Profile & Description
6 days ago Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an …See details»
Abeona Therapeutics - Craft
Oct 29, 2024 Dallas, TX HQ. United States. 3333 Lee Pkwy #600. Cleveland, OH. United States. 6555 Carnegie Ave 4th floor. New York, NY. United States. 1330 6th Ave 33rd FloorSee details»
ABEONA THERAPEUTICS LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ABEONA THERAPEUTICS LLC of Cleveland, OH. Get the latest business insights from Dun & Bradstreet.See details»
Abeona Therapeutics - LinkedIn
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeona’s investigational ...See details»
Abeona Therapeutics - Overview, News & Similar companies
Abeona Therapeutics contact info: Phone number: (646) 813-4701 Website: www.abeonatherapeutics.com What does Abeona Therapeutics do? Founded in 2013 and …See details»
Abeona Therapeutics - 2025 Company Profile - Tracxn
Apr 16, 2025 Abeona Therapeutics - Developer of cell and gene therapies for the treatment of rare diseases. Acquired by PlasmaTech Biopharmaceuticals. Raised funding over 6 rounds …See details»
Abeona Therapeutics Information - RocketReach
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeona’s investigational …See details»
Company Information :: Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s lead clinical program is EB-101, its investigational …See details»
Contact Us :: Abeona Therapeutics Inc. (ABEO)
MIRequests@abeonatherapeutics.com 1-844-888-ABEO, Option 1. Adverse Events Reporting/Product Quality SafetyReports@abeonatherapeutics.com 1-844-888-ABEO, Option …See details»
Abeona Therapeutics
Apr 9, 2025 Clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening rare genetic diseasesSee details»
Abeona Therapeutics (LON:0H7R) Company Profile & Description
Apr 16, 2025 Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an …See details»
Abeona Therapeutics Inc. (ABEO)
© 2025 Abeona Therapeutics Inc. All rights reserved. US-COM-ZEV-250033 03/25See details»
Abeona Therapeutics® Reports First Quarter 2025 Financial …
19 hours ago The Company’s development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, …See details»
Products :: Abeona Therapeutics Inc. (ABEO)
© 2025 Abeona Therapeutics Inc. All rights reserved. US-COM-ZEV-250033 03/25See details»
U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the U.S. Food and Drug Administration (FDA) has approved ZEVASKYN™ …See details»
US FDA approves first cell-based gene therapy for rare genetic …
Apr 29, 2025 Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase …See details»
Science :: Abeona Therapeutics Inc. (ABEO)
© 2025 Abeona Therapeutics Inc. All rights reserved. US-COM-ZEV-250033 03/25See details»